The effect of aflatoxin B-1 on cytokine mRNA and corresponding protein levels in peritoneal macrophages and splenic lymphocytes

Male CD-1 mice were used to test the in vivo effects of aflatoxin B-1 (AFB(1)) on the genetic expression of major cytokines produced by macrophages (interleukin (IL)-1 alpha, IL-6 and tumour necrosis factor alpha (TNF)) and splenic lymphocytes (IL-2, interferon gamma (IFN gamma), and IL-3), activated in vitro with lipopolysaccharide (LPS) and concanavalin A (Con A), respectively. Animals were treated with 0, 0.03, 0.145 or 0.7 mg AFB(1)/kg body weight orally every other day for 2 weeks. No significant effects of the toxin on the weights of liver, kidney, spleen, or thymus, or in red blood cell counts were noted, but white blood cell counts were significantly elevated at the low (0.03 mg/kg) dose. Cytokine mRNA levels were measured by Northern blots or cDNA amplification and the secreted protein levels were measured by immunoassay. AFB(1) had a marked effect on macrophage-produced cytokines. The mRNA levels increased significantly at the low (IL-1 alpha) or medium dose (IL-6 and TNF), their corresponding protein levels were generally suppressed. The levels of IL-1 alpha secreted protein were significantly suppressed at all dosages, and those of IL-6 and TNF at the high dose. The low dose of AFB(1) slightly decreased both mRNA and protein levels of lymphocytic IL-2, IFN gamma, and IL-3, only IL-2 mRNA decreasing significantly (P less than or equal to 0.05). It appears that AFB(1) treatment preferentially affects macrophage functions, and in particular, it decouples the close correlation usually observed between transcriptional and translational controls of IL-1 alpha, IL-6 and TNF production by these cells. (C) 1997 International Society for Immunopharmacology.